Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...

The following is a summary of “Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression,” published in the April 2025 issue of BMC ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

A chemotherapeutic assay (ChemoID) designed to to select targeted treatments for patients with platinum-resistant ovarian cancer, based on the cytotoxicity profile of patients’ cancer stem cells, ...

Research and Development, Celularity Inc., Florham Park, NJ, United States Cellular senescence, a state of stable cell cycle arrest, acts as a double-edged sword in cancer biology. In young organisms, ...

Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...

One of the most familiar and widely used methods for quantifying cell proliferation is the measurement of tritiated ... N.J., offers both a [14C]-thymidine and a [3H]-thymidine uptake assay system, ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Researchers have performed the first known ...

Scientists at the University of Bath have developed the first irreversible peptide inhibitors that block the cancer-driving ... Block Survival assay, researchers inserted binding sites for cJun, into ...